10-Q Filing

STREAMEX CORP. CIK: 1530766 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001185185-23-000845`
Period End Date	20230630
Filing Date	20230814
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	biosig20230630_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 76 Cash Flow Statement 70 Stockholders Equity 53

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$357.00K	USD	Point-in-time
Cash	`Cash`	$1.25M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$9.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$21.00K	USD	Point-in-time
Employee advance	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Employee advance	`OtherReceivablesNetCurrent`	$5.00K	USD	Point-in-time
Inventory, short term	`InventoryNet`	$189.00K	USD	Point-in-time
Inventory, short term	`InventoryNet`	$336.00K	USD	Point-in-time
Net investment in leases, short term	`SalesTypeLeaseLeaseReceivable`	$101.00K	USD	Point-in-time
Net investment in leases, short term	`SalesTypeLeaseLeaseReceivable`	$102.00K	USD	Point-in-time
Prepaid expenses and vendor deposits4	`PrepaidExpenseCurrent`	$418.00K	USD	Point-in-time
Prepaid expenses and vendor deposits4	`PrepaidExpenseCurrent`	$325.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$665.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$621.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$705.00K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$561.00K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableOtherCurrent`	-	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableOtherCurrent`	$120.00K	USD	Point-in-time
Inventory, long term	`InventoryNoncurrent`	$1.14M	USD	Point-in-time
Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	105.00	shares	Point-in-time
Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	105.00	shares	Point-in-time
Inventory, long term	`InventoryNoncurrent`	-	USD	Point-in-time
Net investment in leases, long term	`SalesTypeAndDirectFinancingLeasesLeaseReceivable`	$120.00K	USD	Point-in-time
Net investment in leases, long term	`SalesTypeAndDirectFinancingLeasesLeaseReceivable`	$69.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	105.00	shares	Point-in-time
Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	105.00	shares	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$307.00K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$298.00K	USD	Point-in-time
Preferred Stock, liquidation preference (in Dollars)	`TemporaryEquityLiquidationPreference`	$105.00K	USD	Point-in-time
Preferred Stock, liquidation preference (in Dollars)	`TemporaryEquityLiquidationPreference`	$105.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$44.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$514.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$4.11M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Total assets	`Assets`	$4.05M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable and accrued expenses, including $0 and $120 to related parties as of March 31, 2023 and December 31, 2022, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.85M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Accounts payable and accrued expenses, including $0 and $120 to related parties as of March 31, 2023 and December 31, 2022, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.91M	USD	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	$5.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.61M	shares	Point-in-time
Deferred revenue, short term	`DeferredRevenueCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	73.46M	shares	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$91.00K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$96.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	73.46M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.61M	shares	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$313.00K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$330.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.26M	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$452.00K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$282.00K	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$452.00K	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$282.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.71M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.61M	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$105.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 66,857,687 and 54,610,638 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$73.00K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 66,857,687 and 54,610,638 issued and outstanding as of March 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$55.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$234.57M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$216.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-215.97M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-234.40M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc.	`StockholdersEquity`	$313.00K	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc.	`StockholdersEquity`	$242.00K	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$89.00K	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$-21.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$292.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$331.00K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.41M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.98M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$4.05M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$4.11M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$8.00K	USD	1 Quarter
Revenue	`Revenues`	$5.00K	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	$16.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.71M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.97M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.77M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.35M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.70M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.30M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$15.35M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$176.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$126.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$71.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$92.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.91M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$18.30M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$5.72M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$13.80M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-18.29M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-10.91M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-13.78M	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$7.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	-	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	-	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$3.00K	USD	1 Quarter
Other income (expense), net:	`OtherNonoperatingIncomeExpense`	$-225.00K	USD	2 Qtrs
Other income (expense), net:	`OtherNonoperatingIncomeExpense`	$-225.00K	USD	1 Quarter
Other income (expense), net:	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income (expense), net:	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.72M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.78M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-18.51M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.13M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net loss	`ProfitLoss`	$-18.51M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.78M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-11.13M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.72M	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-37.00K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.00K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-87.00K	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-59.00K	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-18.43M	USD	2 Qtrs
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-5.76M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-11.09M	USD	1 Quarter
Net loss attributable to BioSig Technologies, Inc.	`NetIncomeLoss`	$-13.72M	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
Preferred stock deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	2 Qtrs
Preferred stock deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$108.00K	USD	1 Quarter
Preferred stock deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$108.00K	USD	2 Qtrs
Preferred stock deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.87M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.10M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.43M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.84M	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-0.16	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-0.36	USD	2 Qtrs
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-0.15	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted1`	$-0.28	USD	2 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	37.92M	shares	2 Qtrs
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	39.82M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	70.28M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted1`	65.88M	shares	2 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-18.51M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.78M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-11.13M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.72M	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$126.00K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$71.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$92.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$176.00K	USD	2 Qtrs
Non-cash lease expense	`DepreciationNonproduction`	$144.00K	USD	2 Qtrs
Non-cash lease expense	`DepreciationNonproduction`	$166.00K	USD	2 Qtrs
Non-cash inventory writedown	`InventoryWriteDown`	$1.31M	USD	2 Qtrs
Non-cash inventory writedown	`InventoryWriteDown`	-	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$6.89M	USD	2 Qtrs
Equity based compensation	`AllocatedShareBasedCompensationExpense`	$2.17M	USD	2 Qtrs
Change in fair value of modified options	`EquityFairValueAdjustment`	-	USD	2 Qtrs
Change in fair value of modified options	`EquityFairValueAdjustment`	$-15.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$12.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Lease receivables	`IncreaseDecreaseInLeasingReceivables`	$-50.00K	USD	2 Qtrs
Lease receivables	`IncreaseDecreaseInLeasingReceivables`	-	USD	2 Qtrs
Employee advances	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Employee advances	`IncreaseDecreaseInOtherReceivables`	$5.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$19.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$145.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$277.00K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$564.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-16.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-5.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$159.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-731.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-167.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-153.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.54M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.64M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$60.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$122.00K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-60.00K	USD	2 Qtrs
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-122.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.99M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.82M	USD	2 Qtrs
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	$302.00K	USD	2 Qtrs
Proceeds from sale of common stock under a At-the-market offering, net of issuance costs	`ProceedsFromOtherEquity`	-	USD	2 Qtrs
Proceeds from the sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromPaymentsToMinorityShareholders`	$1.57M	USD	2 Qtrs
Proceeds from the sale of subsidiary stock to non-controlling interest, net of issuance costs	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$11.56M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.12M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$895.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-6.58M	USD	2 Qtrs
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.25M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$357.00K	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.66M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.08M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.66M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.08M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$357.00K	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.25M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Common stock issued in settlement of debt	`DebtConversionOriginalDebtAmount1`	$105.00K	USD	2 Qtrs
Common stock issued in settlement of debt	`DebtConversionOriginalDebtAmount1`	-	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$5.00K	USD	2 Qtrs
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$5.00K	USD	2 Qtrs
Series C convertible preferred stock deemed dividend	`ConversionOfStockAmountIssued1`	$108.00K	USD	2 Qtrs
Series C convertible preferred stock deemed dividend	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$502.00K	USD	2 Qtrs
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs

Stockholders Equity 53 line items

Line Item	Tag	Value	Unit	Period
Sale of common stock, transactional costs	`PaymentsOfStockIssuanceCosts`	$3.00K	USD	1 Quarter
Sale of common stock, transactional costs	`PaymentsOfStockIssuanceCosts`	$438.00K	USD	1 Quarter
Sale of common stock, transactional costs	`PaymentsOfStockIssuanceCosts`	$482.00K	USD	1 Quarter
Sale of common stock, transactional costs	`PaymentsOfStockIssuanceCosts`	$201.00K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$292.00K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$331.00K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.41M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.98M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	73.46M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	54.61M	shares	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$483.00K	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.06M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$4.81M	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$301.60K	USD	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.10M	USD	1 Quarter
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.60M	USD	1 Quarter
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	260,000.00	shares	Point-in-time
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	2.37M	shares	Annual
Change in fair value of modified options	`OtherNoncashExpense`	$15.00K	USD	1 Quarter
Common stock issued in settlement of debt	`StockValueIssuedInSettlementOfDebt`	$105.00K	USD	1 Quarter
Sale of common stock and warrants, net transactional costs	`StockholdersEquityOther`	$6.75M	USD	1 Quarter
Sale of common stock and warrants, net transactional costs	`StockholdersEquityOther`	$3.25M	USD	1 Quarter
Sale of common stock and warrants, net transactional costs	`StockholdersEquityOther`	$2.82M	USD	1 Quarter
Sale of common stock and warrants, net transactional costs	`StockholdersEquityOther`	$3.00M	USD	1 Quarter
Sale of subsidiary stock	`AdjustmentsToAdditionalPaidInCapitalOther`	$1.57M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$399.00K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.05M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$-317.00K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$-69.00K	USD	1 Quarter
Accretion of deemed preferred stock dividend	`TemporaryEquityAccretionOfDividends`	$108.00K	USD	1 Quarter
Deemed preferred stock dividend	`TemporaryEquityDividendsAdjustment`	$-108.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$5.00K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	$2.00K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$3.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.06M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-18.51M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-13.78M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-11.13M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.46M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$292.00K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$331.00K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.41M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.98M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	73.46M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	54.61M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.